| Breakdown | Mar 2026 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 233.43B | 343.18B | 465.74B | 503.84B | 452.80B |
| Gross Profit | 22.09B | 34.91B | 67.47B | 98.52B | 98.82B |
| EBITDA | -55.07B | -44.74B | 43.73B | 55.55B | 67.04B |
| Net Income | -88.56B | -49.48B | 12.16B | 37.55B | 38.07B |
Balance Sheet | |||||
| Total Assets | 1.02T | 1.29T | 1.50T | 1.76T | 1.94T |
| Cash, Cash Equivalents and Short-Term Investments | 67.31B | 88.34B | 99.83B | 137.23B | 149.37B |
| Total Debt | 209.21B | 235.87B | 278.34B | 339.71B | 294.00B |
| Total Liabilities | 784.76B | 947.41B | 1.10T | 1.35T | 1.55T |
| Stockholders Equity | 116.91B | 202.67B | 250.78B | 242.69B | 235.95B |
Cash Flow | |||||
| Free Cash Flow | -4.18B | -719.76M | -4.42B | -10.08B | -5.46B |
| Operating Cash Flow | -988.13M | 3.80B | 3.91B | 2.75B | 4.11B |
| Investing Cash Flow | 3.69B | 10.81B | -4.62B | -13.03B | -26.28B |
| Financing Cash Flow | -24.92B | -27.67B | -36.81B | 3.44B | -23.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$397.29B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$177.61B | 7.34 | 2.75% | 4.33% | 27.01% | -20.16% | |
73 Outperform | HK$248.58B | 3.64 | 8.80% | 5.18% | 1.05% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$172.05B | 10.85 | 3.54% | 4.54% | -9.39% | -19.08% | |
58 Neutral | HK$58.07B | 51.26 | 0.65% | 3.96% | -23.93% | -90.51% | |
41 Neutral | HK$46.49B | -1.28 | -59.37% | ― | -28.73% | -60.86% |